Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?

Sommerstein, Rami; Kochen, Michael M; Messerli, Franz H.; Gräni, Christoph (2020). Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? Journal of the American Heart Association, 9(7), e016509. American Heart Association 10.1161/JAHA.120.016509

[img]
Preview
Text
Unbenannt.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (133kB) | Preview

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Sommerstein, Rami, Messerli, Franz, Gräni, Christoph

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2047-9980

Publisher:

American Heart Association

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

11 May 2020 15:56

Last Modified:

05 Dec 2022 15:38

Publisher DOI:

10.1161/JAHA.120.016509

PubMed ID:

32233753

Uncontrolled Keywords:

ACE2 angiotensin II receptor blocker angiotensin‐converting enzyme inhibitor coronavirus disease 2019 epidemiology infectious diseases

BORIS DOI:

10.7892/boris.143171

URI:

https://boris.unibe.ch/id/eprint/143171

Actions (login required)

Edit item Edit item
Provide Feedback